22,100 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Purchased by Weiss Asset Management LP

Weiss Asset Management LP purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSIFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 22,100 shares of the medical instruments supplier’s stock, valued at approximately $1,679,000.

A number of other hedge funds also recently bought and sold shares of MMSI. Valued Wealth Advisors LLC purchased a new position in Merit Medical Systems in the 4th quarter worth about $29,000. Parallel Advisors LLC grew its stake in shares of Merit Medical Systems by 114.6% during the 4th quarter. Parallel Advisors LLC now owns 397 shares of the medical instruments supplier’s stock valued at $30,000 after acquiring an additional 212 shares during the period. Tompkins Financial Corp bought a new position in shares of Merit Medical Systems during the 4th quarter valued at approximately $38,000. Headlands Technologies LLC bought a new position in Merit Medical Systems in the 3rd quarter worth approximately $41,000. Finally, DekaBank Deutsche Girozentrale bought a new position in Merit Medical Systems in the 3rd quarter worth approximately $67,000. Institutional investors own 99.66% of the company’s stock.

Insider Activity

In related news, Director Thomas James Gunderson sold 18,157 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $76.03, for a total transaction of $1,380,476.71. Following the sale, the director now owns 19,257 shares of the company’s stock, valued at $1,464,109.71. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, insider Joseph Wright sold 25,000 shares of the business’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $75.68, for a total transaction of $1,892,000.00. Following the sale, the insider now owns 42,223 shares in the company, valued at $3,195,436.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Thomas James Gunderson sold 18,157 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $76.03, for a total value of $1,380,476.71. Following the sale, the director now owns 19,257 shares in the company, valued at approximately $1,464,109.71. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,637 shares of company stock worth $3,751,673. Company insiders own 3.70% of the company’s stock.

Analyst Ratings Changes

MMSI has been the subject of several recent analyst reports. Bank of America initiated coverage on Merit Medical Systems in a research note on Wednesday, February 7th. They issued a “neutral” rating and a $87.00 price target for the company. Needham & Company LLC dropped their price target on Merit Medical Systems from $88.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. CL King initiated coverage on Merit Medical Systems in a research note on Thursday, April 11th. They issued a “buy” rating and a $88.00 price target for the company. StockNews.com upgraded Merit Medical Systems from a “hold” rating to a “buy” rating in a research report on Thursday, May 2nd. Finally, Barrington Research increased their target price on Merit Medical Systems from $98.00 to $100.00 and gave the company an “outperform” rating in a research report on Wednesday, May 1st. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus price target of $92.78.

Read Our Latest Research Report on Merit Medical Systems

Merit Medical Systems Trading Up 0.8 %

NASDAQ:MMSI traded up $0.61 during midday trading on Thursday, hitting $81.04. 67,482 shares of the company traded hands, compared to its average volume of 458,421. The firm’s fifty day moving average is $76.43 and its 200-day moving average is $75.84. Merit Medical Systems, Inc. has a 12-month low of $62.58 and a 12-month high of $85.62. The firm has a market capitalization of $4.71 billion, a P/E ratio of 46.63, a P/E/G ratio of 2.27 and a beta of 0.91. The company has a current ratio of 6.03, a quick ratio of 4.38 and a debt-to-equity ratio of 0.65.

Merit Medical Systems (NASDAQ:MMSIGet Free Report) last released its earnings results on Tuesday, April 30th. The medical instruments supplier reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. Merit Medical Systems had a return on equity of 15.02% and a net margin of 7.94%. The business had revenue of $323.51 million for the quarter, compared to analyst estimates of $315.57 million. During the same quarter last year, the firm posted $0.64 earnings per share. The business’s revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts predict that Merit Medical Systems, Inc. will post 3.33 EPS for the current year.

About Merit Medical Systems

(Free Report)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.

Recommended Stories

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.